OPA1, a molecular regulator of dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is a disease with no specific treatment, poor prognosis and high mortality. During DCM development, there is apoptosis, mitochondrial dynamics imbalance and changes in cristae structure. Optic atrophy 1 (OPA1) appears at high frequency in these three aspects. DCM LMNA (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiaqi, Shao, Jianan, Wang, Yaoyao, Wu, Kangxiang, Huang, Mingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568666/
https://www.ncbi.nlm.nih.gov/pubmed/37603376
http://dx.doi.org/10.1111/jcmm.17918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568666/
https://www.ncbi.nlm.nih.gov/pubmed/37603376
http://dx.doi.org/10.1111/jcmm.17918

Ejemplares similares